Edition:
United States

Health News

Photo

FDA to expedite review of Teva drug for movement disorder 8:37am EST

TEL AVIV Israel-based Teva Pharmaceutical Industries said on Tuesday the U.S. Food and Drug Administration (FDA) has granted "priority review" for its SD-809 drug to treat tardive dyskinesia with a target date for approval by Aug. 30.

More Headlines

Photo

Business groups, once tobacco-friendly, switch sides in fight

NEW YORK The local chamber of commerce is usually a reliable ally in battles against regulation. But when it comes to smoking rules, many business groups have decided they would rather switch than fight.

7:03am EST

Roche to start new trial of AC Immune drug against Alzheimer's

ZURICH Roche is starting a second late-stage trial of investigational Alzheimer's drug crenezumab that it is developing with Swiss biotech AC Immune, shrugging off failures of similar drugs against the memory-robbing disease.

3:17am EST
Photo

Grain traders prepping fish oil substitutes for aquaculture, health fads

The world's top agricultural traders and biotechnology firms are finding novel ways to make fish oil substitutes from grains and algae as they seek to cash in on consumer health fads that have led to a scarcity of the fatty acids commonly found in fish.

9:45am EST
Photo

Trump seeks help of insurers to smooth Obamacare transition

NEW YORK/WASHINGTON President Donald Trump sought on Monday to bring the nation's largest insurance companies on board with his plans to overhaul Obamacare, saying their help was needed to deliver a smooth transition to the Republicans' new plan.

Politics, Election 2016, Feb 27 2017

More From Around the Web

Health Watch Graphics